Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surfactant protein A (SP-A) and surfactant protein D (SP-D) are large, hydrophilic, multidomain glycoproteins of the collectin family, characterized by collagen-like regions and C-type lectin carbohydrate recognition domains. They are primarily produced by alveolar type II epithelial cells in the lung and are also found on other mucosal surfaces. Their critical function is as pattern recognition molecules in the innate immune system: they bind carbohydrates and lipids on pathogen surfaces in a calcium-dependent manner, leading to aggregation, neutralization, and enhanced clearance by phagocytes. Both SP-A and SP-D regulate inflammation—dampening excessive responses under basal conditions but supporting pro-inflammatory pathways when pathogen burden is high. They are essential for pulmonary homeostasis and protection against infection, with roles in both lung and extrapulmonary immune defense. Recombinant versions are in development as potential therapies for respiratory infections and inflammatory lung diseases[1][2][3][5][6].
Pathogen binding via specific recognition of carbohydrate and lipid moieties on microbial surfaces; Opsonization, facilitating clearance by phagocytes; Direct agglutination and neutralization of pathogens (reducing infectivity and enhancing clearance); Immunomodulation, including downregulation of excess inflammation and modulation of macrophage and neutrophil function[1][3][5][6].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surfactant protein A and Surfactant protein D (SP-A and SP-D).